glp-1 macular degeneration Diabetes Weight Loss Drugs May Double Risk of Diabetic Retinopathy and Glucagon-Like Peptide-1

Yerba mate may contribute to a small caloric deficit through increased expenditure, but it cannot replace the sustained appetite reduction and metabolic changes produced by GLP-1 receptor agonism

nested ophthalmic analysis of the RCT (exenatide) was the only study to conduct formal neuropsychological testing for cognitive function assessment, whereas OLeary et al

N., Calton, E

FDA-approved GLP-1 medications are approved for type 2 diabetes management and chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity

Over the longer term, once weight stabilizes, GLP-1 medications appear to lower uric acid and reduce flare frequency, leaving patients better off

Diabetes 54, 26852693